Belgium's healthcare system is characterized by a strong emphasis on preventative care and high accessibility to specialists. In the realm of endocrinology, there is a surging demand for a continuous glucose monitor to replace traditional finger-stick methods, driven by the Belgian government's push toward digitized patient records and remote monitoring.
Geographically, the urban density of cities like Brussels and Antwerp facilitates a rapid adoption of telehealth. However, the diverse climate of the region requires a glucose monitor patch that maintains adhesive integrity and sensor accuracy across varying humidity levels and temperature fluctuations common in Western Europe.
Economically, the Belgian market is shifting toward value-based reimbursement models. This has accelerated the transition from episodic testing to the use of a continous glucose monitor, as long-term stability in glucose levels significantly reduces the cost of treating diabetes-related complications within the national insurance framework.
